WEST PHARMACEUTICAL SERVICES INC 8-K

What Happened
West Pharmaceutical Services, Inc. filed a Current Report on Form 8-K on February 12, 2026 announcing its fourth-quarter and full-year 2025 financial results via a company press release. The press release and a related presentation were attached to the filing as exhibits.

Key Details

• Filing date: February 12, 2026 (Form 8-K Items 2.02 and 7.01 reported).
• Company materials attached: Exhibit 99.1 — press release dated February 12, 2026; Exhibit 99.2 — presentation dated February 12, 2026; Exhibit 104 — Inline XBRL cover page.
• The report was signed by Robert W. McMahon, Senior Vice President and Chief Financial Officer, on February 12, 2026.
• Item 2.02 discloses results of operations and financial condition (the filing refers investors to the attached press release and presentation for the detailed results).

Why It Matters
Earnings releases provide the updated revenue, profit and operational metrics that investors use to evaluate the company’s recent performance and outlook. West’s press release and investor presentation contain the specific quarterly and full-year figures, trends and any management commentary or guidance — information that can influence investor decisions and the stock’s near-term trading. Retail investors should review the attached press release (Exhibit 99.1) and presentation (Exhibit 99.2) for the full financial details and any commentary on future expectations.